Anti-estrogenic activity of prenylated isoflavones from Millettia pachycarpa: Implications for pharmacophores and unique mechanisms

Journal of Health Science

Volumn 52, Issue 2, 2006, Pages 186-191

  Okamoto, Yoshinori ^a   Suzuki, Atsushi ^a   Ueda, Koji ^a   Ito, Chihiro ^a   Itoigawa, Masataka ^b   Furukawa, Hiroshi ^a   Nishihara, Tsutomu ^c   Kojima, Nakao ^a  

^a MEIJO UNIVERSITY   (Japan)

^b TOKAI GAKUEN UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

4 hydroxytamoxifen; Antiestrogen; Estrogen receptor; Estrogen responsive disease; Leguminosae; Phytochemical

Indexed keywords

4 HYDROXYTAMOXIFEN; 6,8 DIPRENYLOROBOL; ALPINUMISOFLAVONE; ANTIESTROGEN; DAIDZEIN; ERYSENEGALENSEIN E; ESTROGEN RECEPTOR; FUROWANIN A; GENISTEIN; ISOERYSENEGALENSEIN E; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN; PLANT EXTRACT; UNCLASSIFIED DRUG; WARANGALONE; WIGHTEONE;

ARTICLE; CHEMICAL MODIFICATION; CYCLIZATION; ESTROGEN ACTIVITY; HYDROXYLATION; LEGUME; MILLETTIA; MILLETTIA PACHYCARPA; PHARMACOPHORE; PRENYLATION; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

FABACEAE; MILLETTIA;

EID: 33645520496     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.52.186     Document Type: Article

References (16)

1. Yamamoto, S., Sobue, T., Kobayashi, M., Sasaki, S. and Tsugane, S. (2003) Soy, isoflavones, and breast cancer risk in Japan. J. Natl. Cancer Inst., 95, 906-913.
2. Hirose, K., Imaeda, N., Tokudome, Y., Goto, C., Wakai, K., Matsuo, K., Ito, H., Toyama, T., Iwata, H., Tokudome, S. and Tajima, K. (2005) Soybean products and reduction of breast cancer risk: a case-control study in Japan. Br. J. Cancer, 93, 15-22.
3. Nishihara, T., Nishikawa, J., Kanayama, T., Dakeyama, F., Saito, K., Imagawa, M., Takatori, S., Kitagawa, Y., Hori, S. and Utsumi, H. (2000) Estrogenic activities of 517 chemicals by yeast two-hybrid assay. J. Health Sci., 46, 282-298.
4. Ito, C., Itoigawa, M., Kumagaya, M., Okamoto, Y., Ueda, K., Nishihara, T., Kojima, N. and Furukawa, H. (2006) Isoflavonoids with antiestrogenic activity from Millettia pachycarpa. J. Nat. Prod., 69, 138-141.
5. Ahn, E. M., Nakamura, N., Akao, T., Nishihara, T. and Hattori, M. (2004) Estrogenic and antiestrogenic activities of the roots of Moghania philippinensis and their constituents. Biol. Pharm. Bull., 27, 548-553.
6. Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J. and Thun, M. J. (2005) Cancer statistics, 2005. CA Cancer J. Clin., 55, 10-30.
7. Swerdlow, A. J. and Jones, M. E. (2005) Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study. J. Natl. Cancer Inst., 97, 375-384.
8. IARC Working Group (1996) Tamoxifen. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, IARC Press, Lyon, vol. 66, pp. 253-365.
9. Katzenellenbogen, B. S., Montano, M. M., Ekena, K., Herman, M. E. and McInerney, E. M. (1997) William L. McGuire Memorial Lecture. Antiestrogens: mechanisms of action and resistance in breast cancer. Breast Cancer Res. Treat., 44, 23-38.
10. McDonnell, D. P., Connor, C. E., Wijayaratne, A., Chang, C. Y. and Norris, J. D. (2002) Definition of the molecular and cellular mechanisms underlying the tissue-selective agonist/antagonist activities of selective estrogen receptor modulators. Recent Prog. Horm. Res., 57, 295-316.
11. Ito, C., Itoigawa, M., Kojima, N., Tokuda, H., Hirata, T., Nishino, H. and Furukawa, H. (2004) Chemical constituents of Millettia taiwaniana: structure elucidation of five new isoflavonoids and their cancer chemopreventive activity. J. Nat. Prod., 67, 1125-1130.
12. Nishikawa, J., Saito, K., Goto, J., Dakeyama, F., Matsuo, M. and Nishihara, T. (1999) New screening methods for chemicals with hormonal activities using interaction of nuclear hormone receptor with coactivator. Toxicol. Appl. Pharmacol., 154, 76-83.
13. Tyulmenkov, V. V. and Klinge, C. M. (2000) Interaction of tetrahydrocrysene ketone with estrogen receptors alpha and beta indicates conformational differences in the receptor subtypes. Arch. Biochem. Biophys., 381, 135-142.
14. Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J. Å. and Carlquist, M. (1997) Molecular basis of agonism and antagonism in the oestrogen receptor. Nature (London), 389, 753-758.
15. Pike, A. C. W., Brzozowski, A. M., Hubbard, R. E., Bonn, T., Thorsell, A. G., Engström, O., Ljunggren, J., Gustafsson, J. Å. and Carlquist, M. (1999) Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J., 18, 4608-4618.
16. Ono, K., Nakane, H., Meng, Z. M., Ose, Y., Sakai, Y. and Mizuno, M. (1989) Differential inhibitory effects of various herb extracts on the activities of reverse transcriptase and various deoxyribonucleic acid (DNA) polymerases. Chem. Pharm. Bull., 37, 1810-1812.